Like BCMA, GPRC5D is upregulated in neoplastic PCs, and increased GPRC5D mRNA expression from bone marrow or MM cells is associated with a high number of genetic aberrations and high-risk disease [25,27]. The gene discussed is GPRC5D; the disease is Miyoshi myopathy.